Preparing for an FDA Advisory Committee Approval Meeting

Posted 03 December 2015 By Michael Vivion

placeholder+image This article discusses the nuances of FDA Advisory Committee approval meetings and provides an interpretive overview of what regulatory professionals need to know to prepare for a meeting.

Share this article:

Categories: Biologics and biotechnology, Drugs, Medical Devices, Government affairs, Regulatory strategy, Submission and registration, News, US, CBER, CDER, CDRH, Business and Leadership, Communication

Tags: Advisory Committee Meetings, AdComm,

Regulatory Exchange: Latest Updates From the Community